Home » Topics » Regulatory » Patents

Patents
RSS

Kirin Brewery synthesizes agents for arteriosclerosis

Aug. 30, 1996

SKB claims NK3 antagonists for pulmonary disorders

Aug. 30, 1996

SKB reports on PDE IV inhibitor research

Aug. 30, 1996

AChE inhibitor isolated from Penicillium at Kitasato Institute

Aug. 30, 1996

Theratech describes new rheumatiod arthritis diagnosis

Aug. 30, 1996

Beta3-adrenoceptor agonists described by Dainippon

Aug. 30, 1996

CCK antagonists from Warner-Lambert

Aug. 30, 1996

More squalene synthase inhibitors from Pfizer

Aug. 30, 1996

Estrogenic compounds from Sankyo

Aug. 30, 1996

Potent antiinflammatory/antioxidant agents from Alcon

Aug. 30, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...